Viewing Study NCT02932956


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-06 @ 9:42 AM
Study NCT ID: NCT02932956
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-19
First Post: 2016-10-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
Sponsor: Baylor College of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: H-39410- GAP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View